CLINGLIO Meeting in Palma

SoftMining CEO Stefano Piotto was present at CLINGLIO Meeting held in Palma in May 2019. The CLINGLIO project aims to advance a novel drug, 2OHOA, for the treatment of glioblastoma towards an initial market entry in Europe. For this purpose, the CLINGLIO project will encompass a demonstrative phase IIB clinical study to evaluate the efficacy of an innovative therapy, based on 2OHOA and SoC in subjects with primary newly diagnosed glioblastoma.